Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 2001 to 2025 of 2417

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Epiretinal brachytherapy for wet age-related macular degenerationIPG415
Service user experience in adult mental health: improving the experience of care for people using adult NHS mental health servicesCG136
Tocilizumab for the treatment of systemic juvenile idiopathic arthritisTA238
Fulvestrant for the treatment of locally advanced or metastatic breast cancerTA239
Single-port laparoscopic nephrectomyIPG414
Drainage, irrigation and fibrinolytic therapy (DRIFT) for post-haemorrhagic hydrocephalus in preterm infantsIPG412
Magnetic resonance image-guided transcutaneous focused ultrasound for uterine fibroidsIPG413
Healthcare-associated infections: prevention and controlPH36
Mifamurtide for the treatment of osteosarcomaTA235
The EOS 2D/3D imaging systemDG1
Ticagrelor for the treatment of acute coronary syndromesTA236
Arthroscopic femoro–acetabular surgery for hip impingement syndromeIPG408
Minimally invasive oesophagectomyIPG407
Laparoscopic cryotherapy for renal cancerIPG405
Bortezomib and thalidomide for the first‑line treatment of multiple myelomaTA228
Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusionTA229
Agomelatine for the treatment of major depressive episodes (terminated appraisal)TA231
Percutaneous cryotherapy for renal cancerIPG402
Open femoro–acetabular surgery for hip impingement syndromeIPG403
Ambulight PDT for the treatment of non-melanoma skin cancerMTG6
The MIST Therapy system for the promotion of wound healingMTG5
Myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarctionTA73
Erlotinib monotherapy for maintenance treatment of non-small-cell lung cancerTA227
Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying anti-rheumatic drugsTA225
Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphomaTA226

Results per page

  1. 10
  2. 25
  3. 50
  4. All